Related Experiment Video
Updated: Oct 1, 2025

The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
Disrupted Choline Clearance and Sustained Acetylcholine Release In Vivo by a Common Choline Transporter Coding
Eryn Donovan1, Cassandra Avila1, Sarah Klausner1
1Department of Psychology, University of Michigan, Ann Arbor, Michigan 48109.
The neuronal high-affinity choline transporter (CHT) Val89 variant impairs choline transport and acetylcholine release, leading to attentional deficits. This study establishes a mouse model for investigating cholinergic dysfunction in cognitive disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neuronal high-affinity choline transporter (CHT; SLC5A7) is crucial for acetylcholine (ACh) synthesis and release.
- A common CHT coding variant (Ile89Val) is linked to reduced human attentional control and frontal cortex activation.
Purpose of the Study:
- To investigate the functional consequences of the CHT Val89 variant using a CRISPR/Cas9-generated mouse model.
- To assess CHT-mediated choline transport, ACh release, and attentional performance in Val89 mice.
Main Methods:
- CRISPR/Cas9 gene editing to create Val89 variant mice.
- In vivo assessment of choline transport and ACh release.
- Behavioral testing using a visual disruptor task.
- Structural modeling of the CHT protein.
Main Results:
- Val89 mice exhibited over 80% reduced choline clearance in the cortex and over 50% in the striatum.
- Mutant mice showed deficits in sustained ACh release and impaired cognitive flexibility during an attentional challenge.
- CHT density was unaffected, indicating a selective impact on transporter function.
Conclusions:
- The CHT Val89 variant impairs choline transport and cholinergic signaling, leading to attentional deficits.
- The CHT Val89 mouse model provides a valuable tool for studying heritable cognitive disorders linked to cholinergic dysfunction.
- Findings offer a mechanistic framework for understanding attentional phenotypes associated with the human Val89 variant.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:48Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
Published on: January 25, 2019
Related Concept Videos
Cholinergic Neurons: Neurotransmission
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...